Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Joyce A. Goldstein"'
Autor:
Jay E. Slater, Sergio Bonini, Ioana Agache, Claudio Rhyner, Oscar Palomares, Thomas B. Casale, R. Gerth van Wijk, Aziz Sheikh, Cezmi A. Akdis, R. van Ree, Susanne Halken, Elizabeth Angier, Antonella Muraro, S. Vieths, Carlo Pini, Eva-Maria Varga, J. Bridgewater, G. B. Pajno, Marcel H. N. Hoefnagel, Ronald L. Rabin, Dermot Ryan, Gunter J. Sturm, Oliver Pfaar, Steffen Lau, Graham Roberts, M. Timon, Marek Jutel, Joyce A. Goldstein, Montserrat Fernandez-Rivas, Ruby Pawankar, Ludger Klimek, Andreas Bonertz, D. Hamerlijnk, Domingo Barber, Lars K. Poulsen
Publikováno v:
Bonertz, A, Roberts, G, Slater, J E, Bridgewater, J, Rabin, R L, Hoefnagel, M, Timon, M, Pini, C, Pfaar, O, Sheikh, A, Ryan, D, Akdis, C, Goldstein, J, Poulsen, L K, van Ree, R, Rhyner, C, Barber, D, Palomares, O, Pawankar, R, Hamerlijnk, D, Klimek, L, Agache, I, Angier, E, Casale, T, Fernandez-Rivas, M, Halken, S, Jutel, M, Lau, S, Pajno, G, Sturm, G, Varga, E M, van Wijk, R G, Bonini, S, Muraro, A & Vieths, S 2018, ' Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States : An analysis from the EAACI AIT Guidelines Project ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 73, no. 4, pp. 816-826 . https://doi.org/10.1111/all.13357
Bonertz, A, Roberts, G, Slater, J E, Bridgewater, J, Rabin, R L, Hoefnagel, M, Timon, M, Pini, C, Pfaar, O, Sheikh, A, Ryan, D, Akdis, C, Goldstein, J, Poulsen, L K, van Ree, R, Rhyner, C, Barber, D, Palomares, O, Pawankar, R, Hamerlijnk, D, Klimek, L, Agache, I, Angier, E, Casale, T, Fernandez-Rivas, M, Halken, S, Jutel, M, Lau, S, Pajno, G, Sturm, G, Varga, E M, van Wijk, R G, Bonini, S, Muraro, A & Vieths, S 2017, ' Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States : An analysis from the EAACI AIT Guidelines Project ', Allergy . https://doi.org/10.1111/all.13357
Allergy, 73(4), 816-826. Wiley-Blackwell Publishing Ltd
Allergy, 73(4), 816-826. Wiley-Blackwell
Allergy 73 (2018): 816–826. doi:10.1111/all.13357
info:cnr-pdr/source/autori:Bonertz, A; Roberts, G; Slater, J E; Bridgewater, J; Rabin, R L; Hoefnagel, M; Timon, M; Pini, C; Pfaar, O; Sheikh, A; Ryan, D; Akdis, C; Goldstein, J; Poulsen, L K; van Ree, R; Rhyner, C; Barber, D; Palomares, O; Pawankar, R; Hamerlijnk, D; Klimek, L; Agache, I; Angier, E; Casale, T; Fernandez-Rivas, M; Halken, S; Jutel, M; Lau, S; Pajno, G; Sturm, G; Varga, E M; Gerth van Wijk, R; Bonini, S; Muraro, A; Vieths, S/titolo:Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project./doi:10.1111%2Fall.13357/rivista:Allergy/anno:2018/pagina_da:816/pagina_a:826/intervallo_pagine:816–826/volume:73
Bonertz, A, Roberts, G, Slater, J E, Bridgewater, J, Rabin, R L, Hoefnagel, M, Timon, M, Pini, C, Pfaar, O, Sheikh, A, Ryan, D, Akdis, C, Goldstein, J, Poulsen, L K, van Ree, R, Rhyner, C, Barber, D, Palomares, O, Pawankar, R, Hamerlijnk, D, Klimek, L, Agache, I, Angier, E, Casale, T, Fernandez-Rivas, M, Halken, S, Jutel, M, Lau, S, Pajno, G, Sturm, G, Varga, E M, van Wijk, R G, Bonini, S, Muraro, A & Vieths, S 2017, ' Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States : An analysis from the EAACI AIT Guidelines Project ', Allergy . https://doi.org/10.1111/all.13357
Allergy, 73(4), 816-826. Wiley-Blackwell Publishing Ltd
Allergy, 73(4), 816-826. Wiley-Blackwell
Allergy 73 (2018): 816–826. doi:10.1111/all.13357
info:cnr-pdr/source/autori:Bonertz, A; Roberts, G; Slater, J E; Bridgewater, J; Rabin, R L; Hoefnagel, M; Timon, M; Pini, C; Pfaar, O; Sheikh, A; Ryan, D; Akdis, C; Goldstein, J; Poulsen, L K; van Ree, R; Rhyner, C; Barber, D; Palomares, O; Pawankar, R; Hamerlijnk, D; Klimek, L; Agache, I; Angier, E; Casale, T; Fernandez-Rivas, M; Halken, S; Jutel, M; Lau, S; Pajno, G; Sturm, G; Varga, E M; Gerth van Wijk, R; Bonini, S; Muraro, A; Vieths, S/titolo:Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project./doi:10.1111%2Fall.13357/rivista:Allergy/anno:2018/pagina_da:816/pagina_a:826/intervallo_pagine:816–826/volume:73
Adequate quality is essential for any medicinal product to be eligible for marketing. Quality includes verification of the identity, content and purity of a medicinal product in combination with a specified production process and its control. Allerge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd5a9c345a565a9d328eb1140835cd3
https://findresearcher.sdu.dk:8443/ws/files/129379871/Allergen_manufacturing_and_quality_aspects_for_allergen_immunotherapy_in_Europe_and_the_United_States.pdf
https://findresearcher.sdu.dk:8443/ws/files/129379871/Allergen_manufacturing_and_quality_aspects_for_allergen_immunotherapy_in_Europe_and_the_United_States.pdf
Autor:
S. Vieths, Marcel H. N. Hoefnagel, Ruby Pawankar, Gunter J. Sturm, Lars K. Poulsen, Montserrat Fernandez-Rivas, Oliver Pfaar, Domingo Barber, Ioana Agache, Ludger Klimek, Thomas B. Casale, Jay E. Slater, Eva-Maria Varga, Graham Roberts, Cezmi A. Akdis, Antonella Muraro, Joyce A. Goldstein, Ronald L. Rabin, Andreas Bonertz, Oscar Palomares, Aziz Sheikh, D. Hamerlijnk, Carlo Pini, R. van Ree, Susanne Halken, Steffen Lau, Marek Jutel, R. Gerth van Wijk, J. Bridgewater, M. Timon, Sergio Bonini, Claudio Rhyner, Elizabeth Angier, G. B. Pajno
Publikováno v:
Bonertz, A, Roberts, G C, Hoefnagel, M, Timon, M, Slater, J E, Rabin, R L, Bridgewater, J, Pini, C, Pfaar, O, Akdis, C, Goldstein, J, Poulsen, L K, van Ree, R, Rhyner, C, Barber, D, Palomares, O, Sheikh, A, Pawankar, R, Hamerlijnk, D, Klimek, L, Agache, I, Angier, E, Casale, T, Fernandez-Rivas, M, Halken, S, Jutel, M, Lau, S, Pajno, G, Sturm, G, Varga, E M, Gerth van Wijk, R, Bonini, S, Muraro, A & Vieths, S 2018, ' Challenges in the implementation of EAACI guidelines on allergen immunotherapy : A global perspective on the regulation of allergen products ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 73, no. 1, pp. 64–76 . https://doi.org/10.1111/all.13266
Allergy (Online) 73 (2018): 64–76. doi:10.1111/all.13266
info:cnr-pdr/source/autori:Bonertz A.; Roberts G.C.; Hoefnagel M.; Timon M.; Slater J.E.; Rabin R.L.; Bridgewater J.; Pini C.; Pfaar O.; Akdis C.; Goldstein J.; Poulsen L.K.; van Ree R.; Rhyner C.; Barber D.; Palomares O.; Sheikh A.; Pawankar R.; Hamerlijnk D.; Klimek L.; Agache I.; Angier E.; Casale T.; Fernandez-Rivas M.; Halken S.; Jutel M.; Lau S.; Pajno G.; Sturm G.; Varga E.M.; Gerth van Wijk R.; Bonini S.; Muraro A.; Vieths S./titolo:Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products/doi:10.1111%2Fall.13266/rivista:Allergy (Online)/anno:2018/pagina_da:64/pagina_a:76/intervallo_pagine:64–76/volume:73
Bonertz, A, Roberts, G C, Hoefnagel, M, Timon, M, Slater, J E, Rabin, R L, Bridgewater, J, Pini, C, Pfaar, O, Akdis, C, Goldstein, J, Poulsen, L K, van Ree, R, Rhyner, C, Barber, D, Palomares, O, Sheikh, A, Pawankar, R, Hamerlijnk, D, Klimek, L, Agache, I, Angier, E, Casale, T, Fernandez-Rivas, M, Halken, S, Jutel, M, Lau, S, Pajno, G, Sturm, G, Varga, E M, Gerth van Wijk, R, Bonini, S, Muraro, A & Vieths, S 2017, ' Challenges in the implementation of EAACI guidelines on allergen immunotherapy : A global perspective on the regulation of allergen products ', Allergy . https://doi.org/10.1111/all.13266
Allergy, 73(1), 64-76. Wiley-Blackwell Publishing Ltd
Allergy (Online) 73 (2018): 64–76. doi:10.1111/all.13266
info:cnr-pdr/source/autori:Bonertz A.; Roberts G.C.; Hoefnagel M.; Timon M.; Slater J.E.; Rabin R.L.; Bridgewater J.; Pini C.; Pfaar O.; Akdis C.; Goldstein J.; Poulsen L.K.; van Ree R.; Rhyner C.; Barber D.; Palomares O.; Sheikh A.; Pawankar R.; Hamerlijnk D.; Klimek L.; Agache I.; Angier E.; Casale T.; Fernandez-Rivas M.; Halken S.; Jutel M.; Lau S.; Pajno G.; Sturm G.; Varga E.M.; Gerth van Wijk R.; Bonini S.; Muraro A.; Vieths S./titolo:Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products/doi:10.1111%2Fall.13266/rivista:Allergy (Online)/anno:2018/pagina_da:64/pagina_a:76/intervallo_pagine:64–76/volume:73
Bonertz, A, Roberts, G C, Hoefnagel, M, Timon, M, Slater, J E, Rabin, R L, Bridgewater, J, Pini, C, Pfaar, O, Akdis, C, Goldstein, J, Poulsen, L K, van Ree, R, Rhyner, C, Barber, D, Palomares, O, Sheikh, A, Pawankar, R, Hamerlijnk, D, Klimek, L, Agache, I, Angier, E, Casale, T, Fernandez-Rivas, M, Halken, S, Jutel, M, Lau, S, Pajno, G, Sturm, G, Varga, E M, Gerth van Wijk, R, Bonini, S, Muraro, A & Vieths, S 2017, ' Challenges in the implementation of EAACI guidelines on allergen immunotherapy : A global perspective on the regulation of allergen products ', Allergy . https://doi.org/10.1111/all.13266
Allergy, 73(1), 64-76. Wiley-Blackwell Publishing Ltd
Regulatory approaches for allergen immunotherapy (AIT) products and the availability of high-quality AIT products are inherently linked to each other. While allergen products are available in many countries across the globe, their regulation is very
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91acfab3c007023f5c3c2b273120d757
https://findresearcher.sdu.dk:8443/ws/files/161237769/1_EAACI_TF_Allergen_regulatory_issues_noSupplementary_unmarked.pdf
https://findresearcher.sdu.dk:8443/ws/files/161237769/1_EAACI_TF_Allergen_regulatory_issues_noSupplementary_unmarked.pdf
Autor:
Ngome L. Makia, Joyce A. Goldstein
Publikováno v:
Molecular Pharmacology. 89:154-164
Human cytochrome P450 (CYP) 2C enzymes metabolize ∼30% of clinically prescribed drugs and various environmental chemicals. CYP2C8, an important member of this subfamily, metabolizes the anticancer drug paclitaxel, certain antidiabetic drugs, and en
Publikováno v:
Journal of Biological Chemistry. 290:2264-2278
The Mediator complex is vital for the transcriptional regulation of eukaryotic genes. Mediator binds to nuclear receptors at target response elements and recruits chromatin-modifying enzymes and RNA polymerase II. Here, we examine the involvement of
Autor:
John S. Markowitz, Nihal El Rouby, Xinwen Wang, Hao Jie Zhu, Taimour Y. Langaee, Julie A. Johnson, Joyce A. Goldstein
Publikováno v:
Pharmacogenetics and Genomics. 24:381-386
The polymorphic hepatic enzyme CYP2C19 catalyzes the metabolism of clinically important drugs such as clopidogrel, proton-pump inhibitors, and others and clinical pharmacogenetic testing for clopidogrel is increasingly common. The CYP2C19*10 single-n
Autor:
Joyce A. Goldstein, Russell A. Prough, Katalin Monostory, Sailesh Surapureddi, Ngome L. Makia
Publikováno v:
Molecular Pharmacology. 86:125-137
Cytochrome P450 (CYP)2C9 and CYP2C19 are important human enzymes that metabolize therapeutic drugs, environmental chemicals, and physiologically important endogenous compounds. Initial studies using primary human hepatocytes showed induction of both
Publikováno v:
Drug Metabolism and Disposition. 41:398-405
The pregnane X receptor (PXR, NR1I2) plays a pivotal role in the disposition and detoxification of numerous foreign and endogenous chemicals by increasing transcription of numerous target genes, including phase I and II drug-metabolizing enzymes and
Autor:
Joyce A. Goldstein, Arlene S. Bridges, Melanie S. Joy, Yichun Hu, Mary Anne Dooley, Joyce Blaisdell, Kim L. R. Brouwer, Ronald J. Falk, Mary La, Jinzhao Wang, Reginald F. Frye, Susan L. Hogan
Publikováno v:
British Journal of Clinical Pharmacology. 74:445-455
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cancer patients have been well described. The current study was conducted to document the pharmacokinetics of cyclophosphamide and
Autor:
Shu-Yun Zhang, Sherry J. Coulter, Joyce A. Goldstein, Sailesh Surapureddi, Stephen S. G. Ferguson
Publikováno v:
Molecular Pharmacology. 82:529-540
The CYP2C genes are extensively regulated at the transcriptional stage. The present study shows for the first time that CYP2Cs are also regulated post-transcriptionally by microRNAs (miRNAs). By using online search engines, we found potential miRNA r
Autor:
Christine E. Chamberlain, Yuen Yi Hon, Allan D. Kirk, Su-Jun Lee, Douglas A. Hale, Joyce A. Goldstein, Roslyn B. Mannon, Wai-Johnn Sam
Publikováno v:
Transplantation. 92:1342-1347
Sirolimus (SRL) absorption and metabolism are affected by p-glycoprotein-mediated transport and CYP3A enzyme activity, which are further under the influences of cytokine concentrations. This retrospective study determined the associations of adenosin